Bank Julius Baer & Co. Ltd Zurich cut its stake in shares of Confluent, Inc. (NASDAQ:CFLT – Free Report) by 67.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,579 shares of the company’s stock after selling 9,690 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in Confluent were worth $114,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. 1832 Asset Management L.P. bought a new position in shares of Confluent in the first quarter worth approximately $48,547,000. Vanguard Group Inc. increased its stake in Confluent by 7.2% in the 1st quarter. Vanguard Group Inc. now owns 26,620,150 shares of the company’s stock worth $623,976,000 after buying an additional 1,791,588 shares in the last quarter. Alyeska Investment Group L.P. increased its stake in Confluent by 220.2% in the 1st quarter. Alyeska Investment Group L.P. now owns 2,597,346 shares of the company’s stock worth $60,882,000 after buying an additional 1,786,116 shares in the last quarter. Driehaus Capital Management LLC bought a new stake in Confluent during the first quarter valued at about $39,944,000. Finally, Altimeter Capital Management LP lifted its position in shares of Confluent by 11.0% in the first quarter. Altimeter Capital Management LP now owns 13,042,080 shares of the company’s stock valued at $305,706,000 after acquiring an additional 1,295,710 shares in the last quarter. Institutional investors own 78.09% of the company’s stock.
Confluent Stock Performance
Shares of NASDAQ:CFLT opened at $21.06 on Tuesday. The company has a current ratio of 4.01, a quick ratio of 4.01 and a debt-to-equity ratio of 0.98. Confluent, Inc. has a 12 month low of $15.64 and a 12 month high of $37.90. The company has a market capitalization of $7.37 billion, a price-to-earnings ratio of -23.40 and a beta of 0.98. The firm’s 50-day moving average is $21.95 and its 200 day moving average is $22.00.
Wall Street Analyst Weigh In
Several research firms recently issued reports on CFLT. Barclays increased their target price on Confluent from $24.00 to $27.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 28th. Cowen reaffirmed a “hold” rating on shares of Confluent in a report on Tuesday, October 28th. Truist Financial lifted their price objective on shares of Confluent from $27.00 to $29.00 and gave the company a “buy” rating in a research report on Tuesday, October 28th. UBS Group set a $28.00 target price on shares of Confluent in a report on Tuesday, October 28th. Finally, Zacks Research raised shares of Confluent from a “strong sell” rating to a “hold” rating in a report on Monday, September 1st. One analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $27.97.
Check Out Our Latest Stock Analysis on Confluent
Insider Activity at Confluent
In other Confluent news, Director Eric Vishria sold 30,953 shares of the stock in a transaction on Thursday, August 28th. The stock was sold at an average price of $20.00, for a total value of $619,060.00. Following the sale, the director owned 1,123,447 shares in the company, valued at $22,468,940. This trade represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Edward Jay Kreps sold 232,500 shares of Confluent stock in a transaction on Thursday, November 13th. The stock was sold at an average price of $23.53, for a total value of $5,470,725.00. Following the sale, the chief executive officer owned 377,074 shares of the company’s stock, valued at approximately $8,872,551.22. This trade represents a 38.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 839,139 shares of company stock worth $17,816,358 over the last quarter. 13.82% of the stock is owned by insiders.
About Confluent
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
Featured Stories
- Five stocks we like better than Confluent
- How to Read Stock Charts for Beginners
- D-Wave: Time to Buy the Dip? Or is the Fall Just Starting?
- What is a penny stock? A comprehensive guide
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- Are Penny Stocks a Good Fit for Your Portfolio?
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
Want to see what other hedge funds are holding CFLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Confluent, Inc. (NASDAQ:CFLT – Free Report).
Receive News & Ratings for Confluent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Confluent and related companies with MarketBeat.com's FREE daily email newsletter.
